Bristol Myers Squibb Co
Held by 18 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 110122108 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide
In plain English: 18 of the investors we track own this stock. In the latest quarter, 8 of them bought more of it and 11 sold some or all of theirs (1 bought it for the first time). That tells you what they did last quarter — not what the stock will do next.
Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer
Managers holding
18
-2 vs last quarter (like-for-like)
Total value held
$4.52B
Across tracked managers
Average weight ⓘOn average, how big this stock is in the portfolios that own it (its share of each manager's reported portfolio value).
0.4%
Of each manager's book
QoQ value ⓘLike-for-like: only managers that filed both quarters are compared, so a manager filing late (or confidentially) does not look like buying or selling. Includes price changes.
-$877.27M
-26.8% vs last quarter
Net shares bought
-12.4M
Est. net flow -$719.03M
Quarter activity
8 bought · 11 sold
1 new · 3 sold out
Tracked capital in this stock
Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).
Aggregate buying and selling
Net share change reported each quarter
Who owns BMY?
🔒 The 'who added and who trimmed' chart is a Plus feature
You're viewing the Free plan. Upgrade to unlock The 'who added and who trimmed' chart — every paid plan starts with a 7-day free trial, and you can cancel in two clicks.
Who owns BMY? — Q2 2026
Holders ranked by position size, with each one's quarter-over-quarter change.
Column filters
| # | Manager | Fund | Shares | Value ↓ | % of their portfolio | QoQ | Δ shares | Δ shares % | Est. Δ value ⓘChange in shares × this quarter's price |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Norges Bank | Norges Bank Investment Management | 36.87M | $2.12B | 0.2% | — | — | — | — |
| 2 | Richard Pzena | Pzena Investment Management | 17.01M | $979.95M | 2.9% | Reduced | -88.7K | -0.5% | -$5.11M |
| 3 | Two Sigma | Two Sigma Investments | 10.09M | $581.12M | 0.4% | Reduced | -1.4M | -12.6% | -$83.53M |
| 4 | LSV Asset Management | LSV Asset Management | 9.85M | $567.69M | 1.0% | Added | +996.9K | +11.3% | +$57.44M |
| 5 | Ken Griffin | Citadel Advisors | 1.57M | $90.60M | 0.1% | Added | +78.1K | +5.2% | +$4.50M |
| 6 | Israel Englander | Millennium Management | 752.58K | $43.36M | 0.0% | Reduced | -5.8M | -88.5% | -$333.78M |
| 7 | John Rogers | Ariel Investments | 696.43K | $40.13M | 0.4% | Reduced | -25.3K | -3.5% | -$1.46M |
| 8 | David Shaw | D.E. Shaw & Co. | 559.41K | $32.23M | 0.0% | Added | +249.6K | +80.5% | +$14.38M |
| 9 | Jeremy Grantham | GMO | 411.48K | $23.71M | 0.1% | Reduced | -20.9K | -4.8% | -$1.20M |
| 10 | Ken Fisher | Fisher Asset Management | 173.40K | $9.99M | 0.0% | Reduced | -30.2K | -14.9% | -$1.74M |
| 11 | Mario Gabelli | GAMCO Investors | 82.67K | $4.76M | 0.0% | Reduced | -4.4K | -5.0% | -$252.78K |
| 12 | Fred Alger | Fred Alger Management | 78.92K | $4.55M | 0.0% | Added | +5.0K | +6.7% | +$285.62K |
| 13 | Bill Miller | Miller Value Partners | 69.50K | $4.00M | 0.9% | Held | 0 | 0.0% | $0 |
| 14 | Boston Partners | Boston Partners Global Investors | 51.84K | $2.99M | 0.0% | Added | +3.3K | +6.8% | +$190.77K |
| 15 | Dodge & Cox | Dodge & Cox | 42.36K | $2.44M | 0.0% | Reduced | -4.6M | -99.1% | -$263.92M |
| 16 | Bridgeway | Bridgeway Capital Management | 40.50K | $2.33M | 0.0% | Added | +3.0K | +8.0% | +$172.86K |
| 17 | Tweedy, Browne & Co | Tweedy, Browne Company LLC | 37.57K | $2.16M | 0.2% | Added | +11.4K | +43.6% | +$657.56K |
| 18 | John Ciampaglia & Eric Sprott | Sprott Inc | 8.52K | $490.63K | 0.0% | New | +8.5K | — | +$490.63K |
Column filters
| Manager | Fund | Shares sold | Value last quarter ↓ |
|---|---|---|---|
| Jim Simons | Renaissance Technologies | -977.1K | $59.26M |
| Steve Cohen | Point72 Asset Management | -531.2K | $32.22M |
| Ray Dalio | Bridgewater Associates | -241.7K | $14.66M |
Politician trades
Column filters
| Politician | Date | Ticker | Asset | Type | Reported range ⓘThe dollar range the politician reported. Exact amounts are not disclosed. | Est. size ⓘOur estimate only: the midpoint of the reported range. | Owner | Account ⓘSubholding Of: the account the trade was in, as named on the report (e.g. an IRA or a brokerage account). The same stock bought on the same day in different accounts is a separate trade in each account. | Filed ↓ | Filing delay ⓘDays between the trade and the report. Over 45 days is late under the STOCK Act. | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ro Khanna Politician | Jun 16, 2026 | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN scanned | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Jul 6, 2026 | 20 days | PTR ↗ |
| Mike Kelly Politician | May 7, 2026 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | Victoria Kelly Trust ICA | Jun 11, 2026 | 35 days | PTR ↗ |
| Ro Khanna Politician | May 15, 2026 | BMY | BRISTOL-MYERS SQUIBB COMPANY sP CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Jun 9, 2026 | 25 days | PTR ↗ |
| Julie Johnson Politician | Dec 18, 2025 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Chase Brokerage Account (3935) | Jan 15, 2026 | 28 days | PTR ↗ |
| Julia Letlow Politician | Oct 23, 2024 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Merrill Lynch Investment Account #025 | Jan 13, 2026 | 447 days Late | PTR ↗ |
| Julia Letlow Politician | Apr 28, 2025 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Merrill Lynch Investment Account #025 | Jan 13, 2026 | 260 days Late | PTR ↗ |
| Gil Cisneros Politician | Dec 19, 2025 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | 150 Main Street Trust > Bank of America | Jan 12, 2026 | 24 days | PTR ↗ |
| Gil Cisneros Politician | Nov 12, 2025 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | 150 Main Street Trust > Bank of America | Dec 15, 2025 | 33 days | PTR ↗ |
| Julie Johnson Politician | Nov 13, 2025 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Chase Brokerage Account (3935) | Dec 11, 2025 | 28 days | PTR ↗ |
| Ro Khanna Politician | Nov 3, 2025 | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Dec 8, 2025 | 35 days | PTR ↗ |
| Gil Cisneros Politician | Oct 9, 2025 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | — | Nov 18, 2025 | 40 days | PTR ↗ |
| Ro Khanna Politician | Sep 29, 2025 | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN scanned | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Oct 3, 2025 | 4 days | PTR ↗ |
| Ro Khanna Politician | Aug 5, 2025 | BMY | BRISTOL-MYERS SQUIBS COMPANY CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Oct 3, 2025 | 59 days Late | PTR ↗ |
| Val T. Hoyle Politician | Oct 29, 2024 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Fidelity Rollover IRA | Sep 12, 2025 | 318 days Late | PTR ↗ |
| Julie Johnson Politician | Aug 14, 2025 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Chase Brokerage Account (3935) | Sep 11, 2025 | 28 days | PTR ↗ |
| Ro Khanna Politician | Feb 4, 2025 | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN Pi scanned | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Sep 9, 2025 | 217 days Late | PTR ↗ |
| Ro Khanna Politician | Jun 23, 2025 | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Jul 9, 2025 | 16 days | PTR ↗ |
| Virginia Foxx Politician | Jun 24, 2025 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | — | Jul 3, 2025 | 9 days | PTR ↗ |
| Jefferson Shreve Politician | May 12, 2025 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Self | CRT - Standard Unit Trust | Jun 22, 2025 | 41 days | PTR ↗ |
| Ro Khanna Politician | May 19, 2025 | BMY | BRISTOL-MVERS SQUIBB COMPANY cMN scanned | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Jun 10, 2025 | 22 days | PTR ↗ |
| Julie Johnson Politician | Apr 1, 2025 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Merrill Lynch Tax Efficient Core | May 14, 2025 | 43 days | PTR ↗ |
| Greg Landsman Politician | Mar 27, 2025 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Rockefeller Capital Management (2) | Apr 8, 2025 | 12 days | PTR ↗ |
| Julie Johnson Politician | Jan 15, 2025 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Merrill Lynch Tax Efficient Core | Feb 12, 2025 | 28 days | PTR ↗ |
| Virginia Foxx Politician | Dec 6, 2024 | BMY | Bristol-Myers Squibb Company Common Stock (BMY) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | — | Jan 6, 2025 | 31 days | PTR ↗ |
| Ro Khanna Politician | Nov 15, 2024 | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Dec 5, 2024 | 20 days | PTR ↗ |